Donate Help Contact The AHA Sign In Home
American Heart Association
Arteriosclerosis, Thrombosis, and Vascular Biology
Search: search_blue_button Advanced Search
Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:1184-1188

This Article
Right arrow Full Text
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Haffner, S. M.
Right arrow Articles by Howard, B. V.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Haffner, S. M.
Right arrow Articles by Howard, B. V.
(Arteriosclerosis, Thrombosis, and Vascular Biology. 1996;16:1184-1188.)
© 1996 American Heart Association, Inc.


Articles

Apolipoprotein E Polymorphism and LDL Size in a Biethnic Population

Steven M. Haffner; Michael P. Stern; Heikki Miettinen; David Robbins; Barbara V. Howard

the Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio (S.M.H., M.P.S., H.M.), and Medlantic Research Institute, Washington, DC (D.R., B.V.H.).

Correspondence to Steven Haffner, MD, Division of Clinical Epidemiology, Department of Medicine, University of Texas Health Science Center at San Antonio, 7703 Floyd Curl Drive, San Antonio, TX 78284-7873.

Polymorphisms in the apolipoprotein E (apoE) phenotype (especially E4) are associated with increased cardiovascular risk and particularly with increased concentrations of LDL cholesterol. Little is known, however, about whether alterations in LDL size are associated with the apoE4 phenotype. LDL size was determined by gradient gel electrophoresis, and apoE phenotype was determined by isoelectric focus in 337 nondiabetic subjects from the San Antonio Heart Study, a population-based study of diabetes and cardiovascular risk factors in Mexican Americans and non-Hispanic whites. ApoE4 was associated not only with increases in LDL cholesterol concentrations but also with decreased LDL size. After adjustment for age, sex, body mass index, waist-to-hip ratio, triglyceride, HDL cholesterol, fasting insulin, and diabetic status, the apoE phenotype remained significantly related to LDL size (Å) in both men (apoE23, 260.0; apoE33, 256.3; and apoE34, 252.6; P=.01) and women (apoE23, 261.7; apoE33, 257.9; and apoE34, 256.7, P=.045). Variations in apoE phenotype are associated not only with changes in the absolute concentration of LDL cholesterol but also with changes in its composition. These changes are only partly explained by associations of apoE with insulin, triglyceride, and HDL cholesterol.


Key Words: apolipoprotein E • LDL size • LDL cholesterol • triglyceride




This article has been cited by other articles:


Home page
J. Nutr.Home page
J. A. Moreno, F. Perez-Jimenez, C. Marin, P. Gomez, P. Perez-Martinez, R. Moreno, C. Bellido, F. Fuentes, and J. Lopez-Miranda
The Effect of Dietary Fat on LDL Size Is Influenced by Apolipoprotein E Genotype in Healthy Subjects
J. Nutr., October 1, 2004; 134(10): 2517 - 2522.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
Y. Bosse, L. Perusse, and M.-C. Vohl
Genetics of LDL particle heterogeneity: from genetic epidemiology to DNA-based variations
J. Lipid Res., June 1, 2004; 45(6): 1008 - 1026.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
M. A. Austin, K. L. Edwards, S. A. Monks, K. M. Koprowicz, J. D. Brunzell, A. G. Motulsky, M. C. Mahaney, and J. E. Hixson
Genome-wide scan for quantitative trait loci influencing LDL size and plasma triglyceride in familial hypertriglyceridemia
J. Lipid Res., November 1, 2003; 44(11): 2161 - 2168.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
Y. Bosse, L. Perusse, J.-P. Despres, B. Lamarche, Y. C. Chagnon, T. Rice, D.C. Rao, C. Bouchard, and M.-C. Vohl
Evidence for a Major Quantitative Trait Locus on Chromosome 17q21 Affecting Low-Density Lipoprotein Peak Particle Diameter
Circulation, May 13, 2003; 107(18): 2361 - 2368.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K. K. Berneis and R. M. Krauss
Metabolic origins and clinical significance of LDL heterogeneity
J. Lipid Res., September 1, 2002; 43(9): 1363 - 1379.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
F. Schiele, M. Vincent-Viry, M. Starck, B. Beaud, G. Hennache, G. Siest, S. Visvikis, and B. Herbeth
Apolipoprotein E in Apolipoprotein B (apo B)- and Non-apo B-containing Lipoproteins in 3523 Participants in the Stanislas Cohort: Biological Variation and Genotype-specific Reference Limits
Clin. Chem., February 1, 2002; 48(2): 291 - 300.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. M. Dart and B. Cooper
Independent Effects of Apo E Phenotype and Plasma Triglyceride on Lipoprotein Particle Sizes in the Fasting and Postprandial States
Arterioscler Thromb Vasc Biol, October 1, 1999; 19(10): 2465 - 2473.
[Abstract] [Full Text] [PDF]